RARECast

RARECast

Por: RARECast

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.
578 episodios disponibles

Latest episodes of the podcast RARECast

Mostrando página 19 de 29

Ionis CEO Stanley Crooke Discusses Success as a Platform Technology Company 20/02/2019
Orchard Looks toward Harvesting Expanded Gene Therapy Pipeline 13/02/2019
Connecting Rare Disease Patients in India and the United States 06/02/2019
Regenerative Medicine Moves into the Spotlight 30/01/2019
Learning New Tricks from Pathogenic Bacteria to Target the Microbiome 24/01/2019
Orphan Drug Accelerator Spin-Out Tackles Rare Endocrine Disorders 16/01/2019
Aspa Therapeutics Forges Gene Therapy for Rare Neurological Condition 09/01/2019
How Patient-Led Collaborations Are Transforming Rare Disease Drug Discovery and Development 02/01/2019
Sobi Expands Its Immunology Franchise with HLH Drug Approval 27/12/2018
Learning to Thrive 19/12/2018
Late-Stage Trial Underway for Treatment of Rare Obesity Disorder 12/12/2018
RegenxBio Bets Its Gene Therapy Technology Provides Competitive Edge 05/12/2018
The Potential for Digital Health Technologies to Transform Clinical Trials 28/11/2018
Matching Volunteers to Rare Disease Organizations in Need 21/11/2018
How One Rare Disease Organization Used Technology to Provide Greater Patient Insight to FDA 14/11/2018
The Potentially Deadly Consequences of an Oversight in Newborn Screening Tests 07/11/2018
Advancing a New Approach to Sickle Cell Disease 31/10/2018
Conquering Life with a Rare Disease 24/10/2018
Why Rare Disease Drug Developers Need Regular Interaction with the FDA 17/10/2018
Making the Case for an FDA Rare Disease Center of Excellence 10/10/2018
« Primera ‹ Anterior 1 ... 17 18 19 20 21 ... 29 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA